How Long Does the Dissociation Effect Last After Spravato?
Spravato (esketamine nasal spray) causes dissociation—sensations of detachment from reality, altered perception, or feeling "spaced out"—as a common side effect tied to its NMDA receptor antagonism. This peaks shortly after administration and fades as drug levels drop.[1]
Patients typically experience dissociation for 1 to 2 hours post-dose, resolving by the end of the mandatory 2-hour monitoring period at clinics. In clinical trials, most reports of moderate to severe dissociation occurred within the first 2 hours, with 7.5% of patients noting it as ongoing but mild beyond that.[2][3]
What Influences Dissociation Duration?
Higher doses (84 mg vs. 56 mg) extend effects slightly, up to 90 minutes for peak intensity. First-time users or those with lower body weight report longer sensory changes. Food slows absorption but doesn't shorten dissociation.[2]
What Happens If Dissociation Lasts Longer?
Rare cases persist 4+ hours, linked to individual metabolism or interactions (e.g., with opioids). Drive or operate machinery is banned for 24 hours regardless, as subtle cognitive fog can linger.[1][3]
How Does This Compare to IV Ketamine?
Spravato's nasal delivery mimics IV ketamine's rapid onset (5-15 minutes) but with shorter dissociation (1-2 hours vs. 30-60 minutes for IV at therapy doses), due to lower bioavailability (~50%).[4]
Patient Tips During Monitoring
Clinics supervise for falls, sedation, or blood pressure spikes alongside dissociation. Effects feel like a "dream state" for many, easing with rest. Report prolonged symptoms to avoid repeat dosing risks.[1]
[1]: Spravato Prescribing Information (FDA)
[2]: SUSTAIN-2 Trial Data (JAMA Psychiatry)
[3]: Spravato Safety Profile (Janssen)
[4]: Ketamine vs. Esketamine Review (Am J Psychiatry)